Clinical feasibility study of early 30-minute dynamic FDG-PET scanning protocol for patients with lung lesions.

"Declarations Ethics approval and consent to participateThis prospective study was approved by the ethics committee of Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences (Clinical Trial Number: KYLH2022-1), which followed the 1964 Helsinki Declaration ethical standards and its subsequent amendments. All patients were provided written informed consent. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This work was supported by the Shenzhen Science and Technology Program of China (JCYJ20220818101804009), Shenzhen High-level Hospital Construction Fund, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen (E010322003, SZ2020MS008), the Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province (2023B1212060052), Shenzhen Science and Technology Innovation Committee (20220531100209020), Department of Science and Technology of Guangdong Province (2022A1515110716)."